The new CEO of a publicly held medical company that recently moved its headquarters to Denver said the company has some work to do.

Dan Greenleaf became the CEO of BioScrip Inc. in September when BioScrip bought Home Solutions, where he previously served as CEO.

On Tuesday, BioScrip announced a loss of $11.1 million for the third quarter, and said revenues declined to $224.5 million from $247 million a year earlier.

“I have just completed my first few weeks with the company and based on my initial review it is clear we have work ahead of us. ... We do not believe our third quarter financial results are indicative of the financial capability of the company and what we will achieve going forward," said Greenleaf in a statement, adding that the company made a "substantive workforce reduction" in late September and October.

Read more at the Denver Business Journal: